Kymera Therapeutics Inc banner

Kymera Therapeutics Inc
NASDAQ:KYMR

Watchlist Manager
Kymera Therapeutics Inc Logo
Kymera Therapeutics Inc
NASDAQ:KYMR
Watchlist
Price: 89.865 USD 1.51% Market Closed
Market Cap: $7.3B

Cash Flow Statement

Cash Flow Statement
Kymera Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
(48)
(44)
(46)
(59)
(58)
(79)
(100)
(124)
(139)
(154)
(155)
(159)
(158)
(168)
(147)
(155)
(158)
(167)
(224)
(241)
(275)
(295)
(311)
Depreciation & Amortization
1
2
2
2
2
2
2
3
3
3
3
3
3
4
4
4
5
6
7
8
8
8
8
Stock-Based Compensation
2
4
5
8
13
18
25
30
34
35
35
37
39
41
43
46
49
52
55
57
58
59
60
Other Non-Cash Items
2
4
7
12
17
24
31
35
39
39
36
36
35
36
38
44
44
45
46
44
47
53
55
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(2)
136
125
110
98
(58)
(62)
(61)
(57)
(40)
(38)
(36)
(34)
(23)
3
8
2
(9)
(24)
(45)
(30)
6
15
Cash from Operating Activities
(47)
N/A
97
N/A
88
-10%
65
-26%
58
-11%
(111)
N/A
(129)
-16%
(146)
-14%
(155)
-6%
(152)
+2%
(153)
-1%
(157)
-2%
(153)
+2%
(151)
+2%
(103)
+32%
(98)
+4%
(106)
-8%
(125)
-17%
(195)
-56%
(234)
-20%
(251)
-7%
(228)
+9%
(233)
-2%
Investing Cash Flow
Capital Expenditures
(6)
(8)
(9)
(9)
(5)
(3)
(2)
(2)
(2)
(3)
(3)
(6)
(16)
(23)
(34)
(38)
(32)
(23)
(13)
(6)
(2)
(2)
(1)
Other Items
(95)
(349)
(413)
(369)
(229)
(33)
(98)
(116)
(95)
5
23
26
(10)
95
174
(177)
(204)
(430)
(391)
(19)
21
(56)
(520)
Cash from Investing Activities
(101)
N/A
(357)
-254%
(423)
-18%
(378)
+10%
(233)
+38%
(36)
+85%
(100)
-179%
(118)
-18%
(97)
+18%
2
N/A
21
+833%
19
-6%
(27)
N/A
71
N/A
140
+96%
(215)
N/A
(235)
-9%
(454)
-93%
(404)
+11%
(25)
+94%
20
N/A
(58)
N/A
(521)
-797%
Financing Cash Flow
Net Issuance of Common Stock
114
297
276
277
186
247
249
249
247
154
154
155
156
6
4
357
357
608
610
257
501
290
992
Net Issuance of Debt
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(2)
(2)
(2)
(1)
(1)
Other
0
14
14
13
13
2
2
2
2
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
114
N/A
310
+173%
289
-7%
290
+0%
199
-31%
249
+25%
250
+1%
250
0%
249
-1%
153
-38%
153
0%
154
+1%
155
+1%
4
-97%
4
-3%
357
+8 410%
357
+0%
608
+70%
609
+0%
255
-58%
500
+96%
288
-42%
991
+244%
Change in Cash
Net Change in Cash
(34)
N/A
51
N/A
(45)
N/A
(23)
+49%
24
N/A
102
+329%
21
-79%
(15)
N/A
(3)
+77%
4
N/A
20
+484%
16
-20%
(25)
N/A
(75)
-202%
41
N/A
43
+4%
15
-65%
30
+95%
10
-65%
(4)
N/A
268
N/A
2
-99%
237
+10 489%
Free Cash Flow
Free Cash Flow
(53)
N/A
90
N/A
79
-12%
56
-29%
54
-4%
(113)
N/A
(131)
-15%
(148)
-14%
(157)
-6%
(155)
+1%
(156)
-1%
(163)
-5%
(169)
-4%
(174)
-3%
(137)
+21%
(136)
+1%
(138)
-1%
(148)
-7%
(207)
-40%
(240)
-16%
(253)
-5%
(230)
+9%
(234)
-2%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett